Pfizer extends HIV/AIDS drug program in Africa, Haiti
BY Advocate.com Editors
January 14 2003 12:00 AM ET
Pharmaceutical companies Pfizer Inc. and the Pfizer Foundation announced Monday an agreement to indefinitely extend their Diflucan Partnership Program in southern Africa and Haiti, according to AIDS Weekly. The program provides free doses of the drug Diflucan, which treats two opportunistic infections associated with HIV/AIDS.
"At Pfizer, we know that the battle against HIV/AIDS must be fought on many fronts," said Pfizer chairman and CEO Hank McKinnell. "Through new and expanded programs, we are helping get medicines to those most in need, showing Pfizer employees how they can help fight the pandemic, and partnering with international organizations to provide care, treatment, and prevention in the countries hardest hit by HIV/AIDS."
The Pfizer Foundation also announced the awarding of $1.8 million to 12 organizations through its new International HIV/AIDS Health Literacy Grants Program. The organizations selected will conduct HIV/AIDS health literacy programs in the countries hardest hit by the pandemic.
- World World Bank President Withdraws From Panel on 'Economic Impact of Homophobia' 44 min 54 sec ago
- Transgender Google's International Women's Day Doodle Includes Trans Women 51 min 1 sec ago
- Sports College Swimmer Comes Out to Religious Mom 1 hour 10 min ago
- Media CNN to Test New Don Lemon Prime-Time Show 1 hour 24 min ago
- Religion WATCH: Christian Pastors Involved in African LGBT Issues — But Not How You May Think 1 hour 40 min ago
- Love and Sex Single, Fun, Fit, and 50 1 hour 52 min ago
- Travel Travelogue: News and Notes from Philly, San Diego and More 2 hours 9 min ago